|
1
|
Yang T, Zeng H, Chen W, Zheng R, Zhang Y,
Li Z, Qi J, Wang M, Chen T, Lou J, et al: Helicobacter pylori
infection, H19 and LINC00152 expression in serum and risk of
gastric cancer in a Chinese population. Cancer Epidemiol.
44:147–153. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colquhoun A, Arnold M, Ferlay J, Goodman
KJ, Forman D and Soerjomataram I: Global patterns of cardia and
non-cardia gastric cancer incidence in 2012. Gut. 64:1881–1882.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sempere LF: Integrating contextual miRNA
and protein signatures for diagnostic and treatment decisions in
cancer. Expert Rev Mol Diagn. 11:813–827. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Imam JS, Buddavarapu K, LeeChang JS,
Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses
tumor growth and progression by targeting the Six1 oncogene in
human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin ZW, Jiang W and Wang L: Biomarkers for
gastric cancer: Progression in early diagnosis and prognosis
(Review). Oncol Lett. 9:1502–1508. 2015.PubMed/NCBI
|
|
6
|
Yao Q, Cao Z, Tu C, Zhao Y, Liu H and
Zhang S: MicroRNA-146a acts as a metastasis suppressor in gastric
cancer by targeting WASF2. Cancer Lett. 335:219–224. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hou Z, Xie L, Yu L, Qian X and Liu B:
MicroRNA-146a is down-regulated in gastric cancer and regulates
cell proliferation and apoptosis. Med Oncol. 29:886–892. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kogo R, Mimori K, Tanaka F, Komune S and
Mori M: Clinical significance of miR-146a in gastric cancer cases.
Clin Cancer Res. 17:4277–4284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boichuk S, Parry JA, Makielski KR,
Litovchick L, Baron JL, Zewe JP, Wozniak A, Mehalek KR,
Korzeniewski N, Seneviratne DS, et al: The DREAM complex mediates
GIST cell quiescence and is a novel therapeutic target to enhance
imatinib-induced apoptosis. Cancer Res. 73:5120–5129. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grimson A, Farh KK, Johnston WK,
GarrettEngele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jensen EH and Tuttle TM: Preoperative
staging and postoperative surveillance for gastric cancer. Surg
Oncol Clin N Am. 16:329–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duan X, Cao W, Wang L, Liu S, Liu Z, Zhang
B, Yang H, Feng T, Zhang J, Zhang X, et al: Genetic variants in
TERT are associated with risk of gastric cancer in a Chinese Han
population. Oncotarget. Nov 4–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
13
|
Takahashi TY, Saikawa Y and Kitagawa Y:
Gastric cancer: Current status of diagnosis and treatment. Cancers
(Basel). 5:48–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsumoto K, Ueyama H, Matsumoto K,
Akazawa Y, Komori H, Takeda T, Murakami T, Asaoka D, Hojo M, Tomita
N, et al: Clinicopathological features of alpha-fetoprotein
producing early gastric cancer with enteroblastic differentiation.
World J Gastroenterol. 22:8203–8210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He CZ, Zhang KH, Li Q, Liu XH, Hong Y and
Lv NH: Combined use of AFP, CEA, CA125 and CAl9-9 improves the
sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol.
13:872013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu WY, Xue XY, Chen ZJ, Han SL, Huang YP,
Zhang LF, Zhu GB and Shen X: Potentially predictive microRNAs of
gastric cancer with metastasis to lymph node. World J
Gastroenterol. 17:3645–3651. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu HS and Xiao HS: MicroRNAs as potential
biomarkers for gastric cancer. World J Gastroenterol.
20:12007–12017. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui L, Zhang X, Ye G, Zheng T, Song H,
Deng H, Xiao B, Xia T, Yu X, Le Y and Guo J: Gastric juice
MicroRNAs as potential biomarkers for the screening of gastric
cancer. Cancer. 119:1618–1626. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu JL, Gao W, Kang QM, Zhang XJ and Yang
SG: Prognostic value of survivin in patients with gastric cancer: A
systematic review with meta-analysis. PLoS One. 8:e719302013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cerne JZ, Gersak K and Novakovic S: The
influence of the genetic variant within miRNA-binding site in
estrogen receptor alpha gene on the risk of breast cancer in
postmenopausal women on hormone replacement therapy. Cancer
Biomark. 8:123–128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim BH, Hong SW, Kim A, Choi SH and Yoon
SO: Prognostic implications for high expression of oncogenic
microRNAs in advanced gastric carcinoma. J Surg Oncol. 107:505–510.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Song YX and Wang ZN: Non-coding
RNAs in gastric cancer. Gene. 560:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zandberga E, Kozirovskis V, Ābols A,
Andrējeva D, Purkalne G and Linē A: Cell-free microRNAs as
diagnostic, prognostic, and predictive biomarkers for lung cancer.
Genes Chromosomes Cancer. 52:356–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Verma M, Lam TK, Hebert E and Divi RL:
Extracellular vesicles: Potential applications in cancer diagnosis
prognosis, and epidemiology. BMC Clin Pathol. 15:62015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Migliore C and Giordano S: Resistance to
targeted therapies: A role for microRNAs? Trends Mol Med.
19:633–642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosenfeld N, Aharonov R, Meiri E,
Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S,
Levy A, et al: MicroRNAs accurately identify cancer tissue origin.
Nat Biotechnol. 26:462–429. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY
and Zhu ZG: MiRNA-199a-3p: A potential circulating diagnostic
biomarker for early gastric cancer. J Surg Oncol. 108:89–92. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai H, Yuan Y, Hao YF, Guo TK, Wei X and
Zhang YM: Plasma microRNAs serve as novel potential biomarkers for
early detection of gastric cancer. Med Oncol. 30:4522013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shah MA and Schwartz GK: Cell
cycle-mediated drug resistance: An emerging concept in cancer
therapy. Clin Cancer Res. 7:2168–2181. 2001.PubMed/NCBI
|
|
31
|
Litovchick L, Florens LA, Swanson SK,
Washburn MP and DeCaprio JA: DYRK1A protein kinase promotes
quiescence and senescence through DREAM complex assembly. Genes
Dev. 25:801–813. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sadasivam SS, Duan S and DeCaprio JA: The
MuvB complex sequentially recruits B-Myb and FoxM1 to promote
mitotic gene expression. Genes Dev. 26:474–489. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie L, Jing R, Qi J, Lin Z and Ju S: Drug
resistance-related microRNAs in hematological malignancies:
Translating basic evidence into therapeutic strategies. Blood Rev.
29:33–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rotkrua P, Shimada S, Mogushi K, Akiyama
Y, Tanaka H and Yuasa Y: Circulating microRNAs as biomarkers for
early detection of diffuse-type gastric cancer using a mouse model.
Br J Cancer. 108:932–940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tsujiura M, Komatsu S, Ichikawa D,
Shiozaki A, Konishi H, Takeshita H, Moriumura R, Nagata H,
Kawaguchi T, Hirajima S, et al: Circulating miR-18a in plasma
contributes to cancer detection and monitoring in patients with
gastric cancer. Gastric Cancer. 18:271–279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tiberio P, Callari M, Angeloni V, Daidone
MG and Appierto V: Challenges in using circulating miRNAs as cancer
biomarkers. Biomed Res Int. 2015:7314792015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song J, Bai Z, Han W, Zhang J, Meng H, Bi
J, Ma X, Han S and Zhang Z: Identification of suitable reference
genes for qPCR analysis of serum microRNA in gastric cancer
patients. Dig Dis Sci. 57:897–904. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kroh EM, Parkin RK, Mitchell PS and Tewari
M: Analysis of circulating microRNA biomarkers in plasma and serum
using quantitative reverse transcription-PCR (qRT-PCR). Methods.
50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
